Topical Estriol for Vaginal Health

PHASE1CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Vaginal Health
Interventions
DRUG

estriol

4 ml vaginal cream (1.0 mg estriol/1 ml cream), 3 days/week for approximately 2 months.

DRUG

Placebo

Placebo cream

Trial Locations (2)

60612

University of Illinois at Chicago, Chicago

90502

Harbor-UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

University of Illinois at Chicago

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Tulane University School of Medicine

OTHER

collaborator

Magee-Women's Research Institute

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

Gynuity Health Projects

OTHER